Methyltransferase-like 3-mediated m6A modification of miR-1908-5p contributes to nasopharyngeal carcinoma progression by targeting homeodomain-only protein homeobox. | Methyltransferase-like 3-mediated m6A modification of miR-1908-5p contributes to nasopharyngeal carcinoma progression by targeting homeodomain-only protein homeobox. Zhou Y, Li W. | 02/9/2024 |
miR1908-5p regulates energy homeostasis in hepatocyte models. | miR1908-5p regulates energy homeostasis in hepatocyte models. Soubeyrand S, Lau P, Beehler K, McShane K, McPherson R., Free PMC Article | 01/29/2022 |
Oncogenic miRNA-1908 targets HDAC10 and promotes the aggressive phenotype of cervical cancer cell. | Oncogenic miRNA-1908 targets HDAC10 and promotes the aggressive phenotype of cervical cancer cell. Yu DS, Song XL, Yan C. | 01/8/2022 |
Extracellular microRNA profiling for prognostic prediction in patients with high-grade serous ovarian carcinoma. | Extracellular microRNA profiling for prognostic prediction in patients with high-grade serous ovarian carcinoma. Yoshida K, Yokoi A, Matsuzaki J, Kato T, Ochiya T, Kajiyama H, Yamamoto Y., Free PMC Article | 12/11/2021 |
Regulation of ABO blood group antigen expression by miR-331-3p and miR-1908-5p during hematopoietic stem cell differentiation. | Regulation of ABO blood group antigen expression by miR-331-3p and miR-1908-5p during hematopoietic stem cell differentiation. Kronstein-Wiedemann R, Nowakowska P, Milanov P, Gubbe K, Seifried E, Bugert P, Chavakis T, Tonn T. | 07/10/2021 |
Evaluation of MiR-1908-3p as a novel serum biomarker for breast cancer and analysis its oncogenic function and target genes. | Evaluation of MiR-1908-3p as a novel serum biomarker for breast cancer and analysis its oncogenic function and target genes. Zhu Y, Wang Q, Xia Y, Xiong X, Weng S, Ni H, Ye Y, Chen L, Lin J, Chen Y, Niu H, Chen X, Lin Y., Free PMC Article | 03/13/2021 |
Evidence has been presented for a potential role of miR-1908-5p and miR-3614-5p in Crohn's disease and rheumatoid arthritis disease risk. | Evidence for a potential role of miR-1908-5p and miR-3614-5p in autoimmune disease risk using integrative bioinformatics. Wohlers I, Bertram L, Lill CM. | 10/5/2019 |
Study found that miR-1908 was significantly upregulated in glioma tissues. High level of miR-1908 was correlated with the shorter survival time of glioma, and promoted glioma cell proliferation and invasion and suppressed apoptosis. miR-1908 exerted these functions by regulating SPRY4/RAF1 axis and changing the expression of apoptosis related proteins. | miR-1908 as a novel prognosis marker of glioma via promoting malignant phenotype and modulating SPRY4/RAF1 axis. Chai Z, Fan H, Li Y, Song L, Jin X, Yu J, Li Y, Ma C, Zhou R., Free PMC Article | 07/28/2018 |
Obtained results indicate that miRNAs: miR-499, miR-708 and miR-1908 are the most promising candidates for biomarkers of depression episodes of bipolar disorder. | Dysregulation of miR-499, miR-708 and miR-1908 during a depression episode in bipolar disorders. Banach E, Dmitrzak-Weglarz M, Pawlak J, Kapelski P, Szczepankiewicz A, Rajewska-Rager A, Slopien A, Skibinska M, Czerski P, Hauser J. | 04/21/2018 |
MicroRNA-1908-5p contributes to the oncogenic function of the splicing factor SRSF3 via NKIRAS2 axis in osteosarcoma cells. | MicroRNA-1908-5p contributes to the oncogenic function of the splicing factor SRSF3. Kim HR, Shin CH, Lee H, Choi KH, Nam DH, Ohn T, Kim HH., Free PMC Article | 03/3/2018 |
miR-1908 had a positive role in scar formation by suppressing Ski-mediated inflammation and fibroblast proliferation in vitro and in vivo. | MiR-1908 promotes scar formation post-burn wound healing by suppressing Ski-mediated inflammation and fibroblast proliferation. Xie C, Shi K, Zhang X, Zhao J, Yu J. | 06/3/2017 |
The RP-p53 pathway was activated by miR-1908 mimic. | miR-1908 Overexpression Inhibits Proliferation, Changing Akt Activity and p53 Expression in Hypoxic NSCLC Cells. Ma Y, Feng J, Xing X, Zhou B, Li S, Zhang W, Jiang J, Zhang J, Qiao Z, Sun L, Ma Z, Kong R., Free PMC Article | 03/4/2017 |
Increased microRNA-1908 expression is associated with poor clinical outcome in human osteosarcoma. | MicroRNA-1908 is a biomarker for poor prognosis in human osteosarcoma. Lian D, Wang ZZ, Liu NS. | 12/17/2016 |
Study shows that miR-1908 is overexpressed in osteosarcoma cells and associated with poor patient survival. There is evidence indicating that miR-1908 has oncogenic and invasion regulatory effects mediated by PTEN in osteosarcoma cells. | MicroRNA-1908 is upregulated in human osteosarcoma and regulates cell proliferation and migration by repressing PTEN expression. Yuan H, Gao Y. | 08/13/2016 |
Overexpression of miR-1908 suppressed the expressions of TGF-beta1, smad2/3 and MMP-2 in human primary renal interstitial cells. | [Transfected miR-1908 inhibits renal fibrosis via targeting transforming growth factor beta 1]. Xie F, Li X, Wei C, Gou L, Dang Y, Shan Z. | 07/2/2016 |
Overexpression of miR-1908 in hMADS cells inhibited adipogenic differentiation and increased cell proliferation, suggesting that miR-1908 is involved in regulation of adipocyte cell differentiation and metabolism, and may have an effect on human obesity. | The biological effects of hsa-miR-1908 in human adipocytes. Yang L, Shi CM, Chen L, Pang LX, Xu GF, Gu N, Zhu LJ, Guo XR, Ni YH, Ji CB. | 05/21/2016 |
miRNA-1908 functions as an oncogene in glioblastoma by repressing the PTEN pathway. MiR-1908 is a potential new molecular marker for predicting the risk of recurrence and prognosis of glioblastoma. | MicroRNA-1908 functions as a glioblastoma oncogene by suppressing PTEN tumor suppressor pathway. Xia X, Li Y, Wang W, Tang F, Tan J, Sun L, Li Q, Sun L, Tang B, He S., Free PMC Article | 03/26/2016 |
Study identifies miR-1908, miR-199a-5p, and miR-199a-3p as endogenous promoters of metastatic invasion, angiogenesis, and colonization in melanoma. These miRNAs convergently target ApoE and the heat shock factor DNAJA4. | Convergent multi-miRNA targeting of ApoE drives LRP1/LRP8-dependent melanoma metastasis and angiogenesis. Pencheva N, Tran H, Buss C, Huh D, Drobnjak M, Busam K, Tavazoie SF., Free PMC Article | 01/26/2013 |